Primary information |
---|
sequence ID | Seq_8401 |
Peptide sequence | TLSLPELEQ |
CancerPDF_ID | CancerPDF_ID363, CancerPDF_ID9308, |
PMID | 19795908,24694173 |
Protein Name | Apolipoprotein A-IV,Apolipoprotein A-IV |
UniprotKB Entry Name | APOA4_HUMAN,APOA4_HUMAN |
Fluid | Plasma,Ascites fluid |
M/Z | 515.27,NA |
Charge | 2,1 |
Mass (in Da) | NA,NA |
fdr | NA,NA |
Profiling Technique | LC-MS,LTQ-Orbitrap XL |
Peptide Identification technique | MALDI-TOF/TOF,X tandem for peptide identification |
Quantification Technique | LC-MRM (multiple reaction monitoring),NA |
Labelled/Label Free | Labelled,Label Free |
FDR | less than 7%,NA |
CancerPDF_ID | CancerPDF_ID363, CancerPDF_ID9308, |
p-Value | NA,NA |
Software | FlexAnalysis 3.0 and Biotools 3.0 software,"X tandem for peptide identification,Scaffold 2 software for any modification analysis" |
Length | 9,9 |
Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Ovarian cancer |
Database | NCBI refseq Protein Database,IPI00304273 |
Modification | NA,NA |
Number of Patients | "40 normal, 28 patients",3 ovarian cancer patient and 3 non cancerous control |
Regulation | NA,Uniquely expressed in ovarian cancer patient |
Validation | NA,NA |
Sensitivity | NA,NA |
Specificity | NA,NA |
Accuracy | NA,NA |
Peptide Atlas | PeptideAtlas |
IEDB | |